Sleep Apnea and Pulmonary Hypertension: Pressure in the Wrong Circuit
Around three in ten people with sleep apnea have raised pressure in the lung circulation. And unusually for a comorbidity on this site, there is genetic evidence pointing to a causal direction rather than just an association.
Roughly 29% of people with obstructive sleep apnea have pulmonary hypertension — raised pressure in the arteries feeding the lungs. That figure held up across every sensitivity analysis the reviewers ran, and genetic evidence points toward apnea contributing to it rather than the reverse.
This is the comorbidity on this site with the strongest causal case, and it is also one of the least known to patients.
What pulmonary hypertension is
Blood pressure, as normally measured, is pressure in the systemic circulation — the circuit feeding your body. Pulmonary hypertension is raised pressure in the separate, lower-pressure circuit feeding your lungs.
It matters because the right side of the heart pumps into that circuit. Raise the pressure it has to push against and the right ventricle thickens, then dilates, then fails. The symptoms are unglamorous and easily attributed elsewhere: breathlessness on exertion, fatigue, ankle swelling, light-headedness.
What the evidence shows
On how common it is. A 2025 systematic review and meta-analysis in Sleep and Breathing screened 4,852 records, including 53 studies in the review and 46 in the quantitative analysis — comparing 1,190 apnea patients with pulmonary hypertension against 2,967 without.
- Pooled prevalence using an AHI ≥ 5 threshold: 29.3% (95% CI 19.4–41.8%)
- Heterogeneity was high at I² = 94%, which is the standard caveat on a figure like this
- But the sensitivity analyses barely moved it. Restricting to studies using right-heart catheterisation — the diagnostic gold standard — gave 29.6%. Excluding studies with fewer than 50 participants gave 30.9%. Excluding retrospective designs gave 30.3%
- Using an AHI ≥ 10 threshold, prevalence rose to 35.5%
That stability under sensitivity analysis is what makes this figure more trustworthy than most high-heterogeneity pooled estimates on this site. When a number survives being restricted to the best-designed studies, the heterogeneity is probably about population differences rather than about methodological junk inflating it.
On whether apnea causes it. A 2026 bidirectional Mendelian randomisation study in Respiratory Medicine used pooled genome-wide association data from European populations to test causality in both directions.
Genetically predicted obstructive sleep apnea was positively associated with pulmonary hypertension: OR 1.20 (95% CI 1.01–1.43, P = 0.04). The reverse direction showed nothing (OR 1.00, P = 0.99).
Mendelian randomisation uses genetic variants as natural randomisation, which makes it far more resistant to the confounding that wrecks observational comparisons — obesity in particular. That is why it belongs on this page.
Evidence tier 1 for the prevalence. Tier 2 for the causal claim: an odds ratio of 1.20 with a lower bound of 1.01 and p = 0.04 is only just significant, and MR carries its own assumptions. The direction is informative; the magnitude is soft.
Why would apnea raise lung pressure?
Through hypoxia, and specifically through a reflex that is useful in the short term and harmful when repeated nightly.
When a region of lung is poorly oxygenated, the blood vessels serving it constrict — hypoxic pulmonary vasoconstriction — diverting blood to better-ventilated regions. It is an elegant mechanism for matching blood flow to air.
In sleep apnea the whole lung desaturates, repeatedly, every night. The reflex fires globally instead of locally, raising pulmonary vascular resistance hundreds of times a night. Over years the vessels remodel, and the pressure stops coming back down between events.
Which means the relevant measurement is the oxygen data rather than the event count — the same conclusion the evidence keeps reaching across different outcomes. Hypoxic burden.
Two other conditions sit near this one. Obesity hypoventilation syndrome, where daytime carbon dioxide retention compounds the problem, and COPD-apnea overlap, where two sources of hypoxia combine. Both carry higher pulmonary hypertension risk than apnea alone. Obesity hypoventilation syndrome · COPD and sleep apnea overlap.
What to raise, and when
The symptoms overlap with apnea's own, which is exactly why they get absorbed.
Worth mentioning specifically if you have sleep apnea and any of:
- Breathlessness on exertion that is new, or worse than your fitness explains
- Ankle or leg swelling, which is the sign most specific to right-heart strain
- Light-headedness on exertion, or fainting — this one warrants prompt attention rather than a routine appointment
- Fatigue that persists on well-used CPAP
- A known diagnosis of COPD, obesity hypoventilation, or heart failure alongside the apnea
An echocardiogram is the usual first-line test and it is non-invasive. Right-heart catheterisation is definitive and reserved for when it will change management.
What this does not mean
It does not mean 29% of people who snore have pulmonary hypertension. These were patients with diagnosed apnea in sleep-clinic and cardiology populations, who are sicker than the general snoring population by selection.
It does not mean treating apnea reverses established pulmonary hypertension. The MR finding concerns whether apnea contributes to developing it, not whether CPAP undoes it.
And no consumer product treats obstructive sleep apnea, let alone its cardiovascular consequences. If you have witnessed breathing pauses, gasping arousals, or breathlessness and swelling alongside snoring, that is an assessment rather than a purchase. Snoring versus sleep apnea · What untreated apnea does.